14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BSLN.SW
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Basilea Pharmaceutica AG stock price down 1.47% on Friday
(Updated on May 17, 2024)

Buy or Hold candidate since Mar 28, 2024 Gain 15.94% PDF

The Basilea Pharmaceutica AG stock price fell by -1.47% on the last day (Friday, 17th May 2024) from 44.30 Fr to 43.65 Fr. During the last trading day the stock fluctuated 1.61% from a day low at 43.60 Fr to a day high of 44.30 Fr. The price has risen in 8 of the last 10 days and is up by 10.23% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -33 thousand shares and in total, 14 thousand shares were bought and sold for approximately 600.10 Fr thousand.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 21.22% during the next 3 months and, with a 90% probability hold a price between 48.10 Fr and 54.42 Fr at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BSLN.SW Signals & Forecast

The Basilea Pharmaceutica AG stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at 43.61 Fr and 40.95 Fr. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 14, 2024, and so far it has fallen -1.91%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Basilea Pharmaceutica AG stock

Basilea Pharmaceutica AG finds support from accumulated volume at 43.15 Fr and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved 0.700 Fr between high and low, or 1.61%. For the last week the stock has had daily average volatility of 1.98%.

Our recommended stop-loss: 41.82 Fr (-4.19%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (BSLN.SW) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Basilea Pharmaceutica AG to open at 43.85 Fr, and during the day (based on 14 day Average True Range), to move between 42.58 Fr and 44.72 Fr, which gives a possible trading interval of +/-1.07 Fr (+/-2.45%) up or down from last closing price. If Basilea Pharmaceutica AG takes out the full calculated possible swing range there will be an estimated 4.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 43.90 Fr (0.57%) than the support at 43.15 Fr (1.15%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Basilea Pharmaceutica AG stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Basilea Pharmaceutica AG stock to perform well in the short-term.

Current score: 2.850 Buy Candidate Unchanged

Predicted Opening Price for Basilea Pharmaceutica AG of Tuesday, May 21, 2024

Fair opening price May 21, 2024 Current price
43.85 Fr ( 0.458%) 43.65 Fr

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BSLN.SW

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 44.55 2.06 %
R2 44.28 1.45 %
R1 44.12 1.07 %
Current price: 43.65
Support S1 43.58 -0.154 %
S2 43.42 -0.533 %
S3 43.15 -1.15 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.50 1.95 %
R2 44.30 1.49 %
R1 43.90 0.573 %
Current price 43.65
Support S1 43.15 -1.15%
S2 35.90 -17.75%
S3 35.15 -19.47%

BSLN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 07, 2013 Apr 11, 2013 Jun 21, 2013 5.00 Fr 7.43%

FAQ

What is the symbol for Basilea Pharmaceutica AG Stock and on which exchange is it traded?
The symbol for Basilea Pharmaceutica AG is BSLN.SW and it is traded on the SIX (SIX Swiss Exchange).

Should I buy or sell Basilea Pharmaceutica AG Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Basilea Pharmaceutica AG stock to perform well in the short-term.

How to buy Basilea Pharmaceutica AG Stock?
Basilea Pharmaceutica AG Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Basilea Pharmaceutica AG Stock.

What's the current price of Basilea Pharmaceutica AG Stock?
As of the end of day on the May 17, 2024, the price of an Basilea Pharmaceutica AG (BSLN.SW) share was 43.65 Fr.

What is the 52-week high and low for Basilea Pharmaceutica AG Stock?
The 52-week high for Basilea Pharmaceutica AG Stock is 49.00 Fr and the 52-week low is 32.00 Fr.

What is the market capitalization of Basilea Pharmaceutica AG Stock?
As of the May 17, 2024, the market capitalization of Basilea Pharmaceutica AG is 526.923M.

When is the next earnings date for Basilea Pharmaceutica AG?
The upcoming earnings date for Basilea Pharmaceutica AG is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Basilea Pharmaceutica AG

Basilea Pharmaceutica AG Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union, as well as in Phase III clinical trials for invasive fungal infections in Jap... BSLN.SW Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT